Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }
TSX Venture Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 1.100
Day High 1.100
Open:1.100
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Medicure Inc is a specialty pharmaceutical company. It is involved in research, clinical development, and commercialization of human therapeutics for United States hospital market. Its main focus is on sale and marketing of its drug Aggrastat which is a glycoprotein GP IIb/IIIa receptor antagonist, is used for the treatment of acute coronary syndrome including unstable angina. The firm derives the majority of its revenue geographically from the United States.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports+

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Medicure Announces Normal Course Issuer Bid
- PR Newswire - PRF - Mon Jun 29, 4:30PM CDT
PR Newswire - PRF - CMTX
Mon Jun 29, 4:30PM CDT
WINNIPEG, MB, /PRNewswire/ - Medicure Inc. ("" or the "") (TSXV: MPH) (OTC: MCUJF), a pharmaceutical company, is pleased to announce that the TSX Venture Exchange ("") has accepted the Company's notice of intention to make a normal course issuer bid ("").
Medicure Announces Normal Course Issuer Bid
- PR Newswire - Mon Jun 29, 4:30PM CDT
PR Newswire - PRNW
Mon Jun 29, 4:30PM CDT
WINNIPEG, MB, June 29, 2020 /PRNewswire/ - Medicure Inc. (" Medicure " or the " Company ") (TSXV: MPH) (OTC: MCUJF), a pharmaceutical company, is pleased to announce that the TSX Venture Exchange (" TSXV ") has accepted the Company's notice of intention to make a normal course issuer bid (" NCIB ").
Medicure Announces Positive Results for AGGRASTATœ in the FABOLUS-FASTER Trial and Publication in the Journal - Circulation
- PR Newswire - PRF - Mon Jun 29, 8:06AM CDT
PR Newswire - PRF - CMTX
Mon Jun 29, 8:06AM CDT
, /PRNewswire/ - Medicure Inc. ("" or the "") (TSXV: MPH) (OTC: MCUJF), a pharmaceutical company, today announced that results from the investigator sponsored FABOLUS-FASTER Phase 4 clinical trial, using AGGRASTAT, have been published in Circulation, a peer-reviewed journal of the American Heart Association.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 0.930 +18.28% increase
on 06/15/20
Period Open:1.100
Price movement based on the high, low and last over the given period.
1.140 -3.51% decrease
on 06/30/20
unch (unch) no change
since 06/03/20
3-Month 0.930 +18.28% increase
on 06/15/20
Period Open:1.610
Price movement based on the high, low and last over the given period.
2.800 -60.71% decrease
on 04/15/20
-0.510 (-31.68%) decrease
since 04/03/20
52-Week 0.930 +18.28% increase
on 06/15/20
Period Open:4.900
Price movement based on the high, low and last over the given period.
5.240 -79.01% decrease
on 11/04/19
-3.800 (-77.55%) decrease
since 07/03/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies